BriaCell Therapeutics Corp. - Warrant expiring 2026 (NQ:BCTXW)

0.0009 UNCHANGED

Last Price Updated: 3:49 PM EST, Feb 26, 2026 Add to My Watchlist

Price and Volume

Volume	0
Open	0.0009
Bid (Size)	0.0007 (25,500)
Ask (Size)	0.0011 (300)
Prev. Close	0.0009
Today's Range	0.0009 - 0.0009
52wk Range	0.0009 - 0.0670
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Wondering what's happening in today's pre-market session? ↗

February 18, 2025

The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

Thursday's session: gap up and gap down stocks ↗

February 06, 2025

The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

Performance

52-Week Range 98.7% below 52-week high

0.0009

0.0052W Low 0.0752W High

BriaCell Therapeutics Corp. - Warrant expiring 2026 (BCTXW) traded between $0.00 and $0.07 over the past 52 weeks and last traded at $0.00, 98.7% below its 52-week high.

Past 12 Months

N/A

-98.4%

-97.8%

YTD -$0.06

1Y -$0.04

BCTXW was -97.8% over the past year, -98.4% year to date.

12 Months vs Market

BCTXW

-97.8%

DIA

+9.9%

SPY

+15.0%

QQQ

+23.7%

IWM

+15.4%

Over the past 12 months BCTXW returned -97.8% versus DIA (Dow) +9.9%, SPY (S&P 500) +15.0%, QQQ (Nasdaq 100) +23.7% and IWM (Russell 2000) +15.4%.

Volume & Liquidity

YTD

87.5K

79.5K

More News

Discover the top movers in Tuesday's pre-market session. ↗

February 04, 2025

Via Chartmill

Which stocks are gapping on Friday? ↗

January 31, 2025

Via Chartmill

BriaCell Therapeutics' Mission: Destroy Breast & Prostate Cancers ↗

January 18, 2023

Via Talk Markets

BriaCell Announces Positive End of Phase II Meeting with the FDA for Bria-IMT(TM) Combination in Advanced Metastatic Breast Cancer ↗

January 18, 2023

Via Talk Markets

BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients

December 14, 2022

Via News Direct

BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients

December 14, 2022

Via TheNewswire.com

BriaCell's Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients ↗

December 13, 2022

Via Benzinga

BriaCell's Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients ↗

December 01, 2022

Via Benzinga

IPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies

November 30, 2022

From ImmunoPrecise Antibodies

Via Business Wire

Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021

August 16, 2021

From Stock News Now

Via AccessWire

Frequently Asked Questions

Is BriaCell Therapeutics Corp. - Warrant expiring 2026 publicly traded?

Yes, BriaCell Therapeutics Corp. - Warrant expiring 2026 is publicly traded.

What exchange does BriaCell Therapeutics Corp. - Warrant expiring 2026 trade on?

BriaCell Therapeutics Corp. - Warrant expiring 2026 trades on the Nasdaq Stock Market

What is the ticker symbol for BriaCell Therapeutics Corp. - Warrant expiring 2026?

The ticker symbol for BriaCell Therapeutics Corp. - Warrant expiring 2026 is BCTXW on the Nasdaq Stock Market

What is the current price of BriaCell Therapeutics Corp. - Warrant expiring 2026?

The current price of BriaCell Therapeutics Corp. - Warrant expiring 2026 is 0.0009

When was BriaCell Therapeutics Corp. - Warrant expiring 2026 last traded?

The last trade of BriaCell Therapeutics Corp. - Warrant expiring 2026 was at 02/26/26 03:49 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.